parp-8

Dehydrocorydaline (13-Methylpalmatine) 是一种生物碱。它调节Bax，Bcl-2蛋白表达，激活caspase-7，caspase-8，并使PARP 失活。它能增强p38 MAPK 活化，具有抗炎、抗癌等功效。它具有强大的抗疟疾作用，并具低细胞毒性。

PARP-2-IN-3 作为一种强效 PARP-2 抑制剂（IC50=0.07 μM），具有抗肿瘤活性，能够诱导癌细胞凋亡(apoptosis)和坏死，可用于研究乳腺癌。

Dehydrocorydaline nitrate 是生物碱。Dehydrocorydaline 调节 Bax，Bcl-2蛋白表达，激活 caspase-7，caspase-8，并使 PARP 失活。它能增强 p38 MAPK 活化，具有抗炎、抗癌、抗疟疾等功效。

PARP1-IN-8 (N-(3-chlorophenyl)-3-(1-oxo-4-phenylphthalazin-2(1H)-yl)propanamide) 是PARP1的有效抑制剂（IC50 = 97 nM）。

Dehydrocorydaline chloride (13-Methylpalmatine chloride) 是生物碱。Dehydrocorydaline 调节 Bax，Bcl-2蛋白表达；激活 caspase-7，caspase-8，并使 PARP 失活。它能增强 p38 MAPK 活化，具有抗炎、抗癌等功效。它具有强大的抗疟疾作用，并具低细胞毒性。

CGP74514A is a CDK1 inhibitor with potential anticancer activity. In U937 cells, CGP74514A - induced apoptosis (5 microM) became apparent within 4 hr and approached 100% by 24 hr. The pan- caspase inhibitor Boc-fmk and the caspase-8 inhibitor lETD-fmk opposed CGP74514A -induced caspase-9 activation and PARP degradation, but not cytochrome c or Smac DIABLO release. CGP74514A -mediated apoptosis was substantially blocked by ectopic expression of full-length Bel- 2, a loop-deleted mutant Bcl-2, and Bcl-x(L). CGP74514A treatment (5 microM; 18 hr) resulted in increased p21(CIP1) expression, p27(KIP1) degradation, diminished E2F1 expression, and dephosphorylation of p34(CDC2). It also induced early (i.e., within 2 hr) inhibition of CDK1 activity and dephosphorylation of pRb, followed by pRb degradation, but did not block pRb phosphorylation at CDK2- and CDK4- specific sites. These findings indicate that the selective CDK1 inhibitor, CGP74514A , induces complex changes in cell cycle......

UPF 1069 是一种特异性PARP 抑制剂，对 PARP-1 和 PARP-2 的IC50值分别为 8 和 0.3 μM。

TopoisomeraseI II inhibitor 8 (Compound Ru7) 是一种双催化抑制剂，能够损伤DNA并激活PARP-1，随后激活RIPK1、RIPK3和MLKL，从而引发坏死性凋亡 (necroptosis)。此化合物展现出显著的抗癌活性，通过坏死性凋亡靶向癌细胞的细胞核，在克服癌症耐药性上具备巨大临床潜力。

Lupiwighteone 是一种广泛存在于野生植物中的异黄酮。它通过抑制 PI3K Akt mTOR 通路，诱导人乳腺癌细胞 caspase 依赖性和非依赖性凋亡，具有抗氧化、抗菌和抗癌作用。